Nov 30, 2016 13:00 pm UTC| Business
ROMAINVILLE, France, Nov. 30, 2016 -- BIOPHYTIS (Alternext Paris:ALBPS), a biotechnology company specialized in the development of drug candidates to treat aging diseases, announces the successful completion of its...
Viracta acquires Phase 2 epigenetic drug candidate from Chroma Therapeutics
Nov 30, 2016 13:00 pm UTC| Business
SAN DIEGO and LONDON, Nov. 30, 2016 -- Viracta Therapeutics, Inc. announced completion of its acquisition of drug development candidate, VRx-3996, from Chroma Therapeutics, Ltd. Viracta plans to advance VRx-3996...
Nov 30, 2016 13:00 pm UTC| Business
PARIS and TOULOUSE, France, Nov. 30, 2016 -- Genticel (Euronext Paris Brussels: FR00011790542 – GTCL), a clinical-stage biotechnology company and developer of innovative immunotherapies, today announced that a...
Nov 30, 2016 12:32 pm UTC| Business
VANCOUVER, British Columbia, Nov. 30, 2016 -- Pure Energy Minerals Limited (TSX VENTURE:PE) (FRANKFURT:A111EG) (OTCQB:PEMIF) (the “Company” or “Pure Energy”) is pleased to announce that it has commenced drilling its...
Nov 30, 2016 12:30 pm UTC| Business
CARMIEL, Israel, Nov. 30, 2016 -- Protalix BioTherapeutics, Inc. (NYSE MKT:PLX) (TASE:PLX), announced today that the first patient has been enrolled in its phase II clinical trial of OPRX-106 for the treatment of...
Match-Trade introduces Ultra-fast Data Feed for FX Brokers
Nov 30, 2016 12:30 pm UTC| Business
Irvine, California, Nov. 30, 2016 -- Match-Trade Technologies LLC, ("Match-Trade" or the "Company"), headquartered in Irvine, California, is pleased to announce the launch of a new service for forex brokers known as the...
Nov 30, 2016 12:30 pm UTC| Business
PHILADELPHIA, Nov. 30, 2016 -- Spark Therapeutics (NASDAQ:ONCE), a fully integrated gene therapy company dedicated to challenging the inevitability of genetic disease, announced today that Katherine High, M.D.,...
U.S. Appeals Court Allows Trump Administration to Enforce Medicaid Funding Ban on Planned Parenthood